Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-063904
Filing Date
2011-11-14
Accepted
2011-11-14 16:00:42
Documents
13
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a11-25918_110q.htm 10-Q 1163494
2 EX-10.15(I) a11-25918_1ex10d15i.htm EX-10.15(I) 42265
3 EX-10.25(I) a11-25918_1ex10d25i.htm EX-10.25(I) 584027
4 EX-31.1 a11-25918_1ex31d1.htm EX-31.1 10314
5 EX-31.2 a11-25918_1ex31d2.htm EX-31.2 10746
6 EX-32.1 a11-25918_1ex32d1.htm EX-32.1 8238
13 GRAPHIC g259181kl01i001.jpg GRAPHIC 3933
  Complete submission text file 0001104659-11-063904.txt   4732154

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT anac-20110930.xml EX-101.INS 642746
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anac-20110930.xsd EX-101.SCH 11524
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anac-20110930_cal.xml EX-101.CAL 39038
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT anac-20110930_lab.xml EX-101.LAB 198278
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anac-20110930_pre.xml EX-101.PRE 90952
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anac-20110930_def.xml EX-101.DEF 64402
Mailing Address 1020 E. MEADOW CIRCLE PALO ALTO CA 94303
Business Address 1020 E. MEADOW CIRCLE PALO ALTO CA 94303 650-543-7500
Anacor Pharmaceuticals Inc (Filer) CIK: 0001411158 (see all company filings)

EIN.: 251854385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34973 | Film No.: 111202250
SIC: 2834 Pharmaceutical Preparations